Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
Clinical trial NCT03114683 · COMPLETED
Trial details
- NCT number
- NCT03114683
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2019-09-12
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.